| 前收市價 | 7.67 |
| 開市 | 7.73 |
| 買盤 | 8.04 x 100 |
| 賣出價 | 8.09 x 500 |
| 今日波幅 | 7.73 - 8.13 |
| 52 週波幅 | 4.90 - 16.65 |
| 成交量 | |
| 平均成交量 | 570,242 |
| 市值 | 544.098M |
| Beta 值 (5 年，每月) | 1.03 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.96 |
| 業績公佈日 | 2024年5月06日 - 2024年5月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 19.14 |
ZacksHow Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%
The mean of analysts' price targets for Oric Pharmaceuticals (ORIC) points to a 39.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ZacksRecent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why
Oric Pharmaceuticals, Inc. (ORIC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
InvestorPlaceFinal Boarding Call: 3 Stocks Set for a Sky-High Surge
Under most financial guidance frameworks, experts advise a long-term approach, which is exactly the opposite ethos when it comes to speculative ideas for high potential stocks. Here, the emphasis centers on getting in, scalping a quick profit and getting out to advantage the next opportunity. To better determine stocks ready to soar, I primarily looked at Fintel’s Short Squeeze Leaderboard. But rather than relying on its proprietary rankings, I decided to look at the combination of short interes
